ISIS-3Scott M. Lieberman · 1991

After ISIS-3Hannaford, PhilipC.; Kay, CliffordR.; Sobel, BurtonE.; Collen, Désiré; Collins, Rory; Peto, Richard; Parish, Sarah; Sleight, Peter; Cowell, R. · 1992

ISIS-3 changes thrombolytic preferencesInpharma Weekly · 1992

Streptokinase proves its value in ISIS-3Inpharma Weekly · 1992

ISIS 3: the last word on thrombolysis?Cobbe, S. · BMJ · 1992

Streptokinase plus aspirin does the trick: ISIS-31992

ISIS-3 does not resolve all the questionsInpharma Weekly · 1992

Computer model accurately predicts chemotherapy responseInpharma Weekly · 2006

AzodicarbonamideInpharma Weekly · 1999

Recommendations for treatment of severe aplastic anaemiaInpharma Weekly · 1994

Did you know about R&D costs?Inpharma Weekly · 1993

R&D investment in JapanInpharma Weekly · 1993

NICE creates new R&D committeeInpharma Weekly · 2003

Gallic acid has potential in lung cancerInpharma Weekly · 2002

New mesalazine formulation advantageous in IBDInpharma Weekly · 2001